mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.07 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.07 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.08 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.08 |